Literature DB >> 122664

Is penicillamine immunostimulant?

E C Huskisson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 122664      PMCID： PMC1543582     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  8 in total

1.  The pathogenesis of rheumatoid arthritis and the mode of action of various drugs: an hypothesis.

Authors:  D A Willoughby; E C Huskisson; P A Dieppe
Journal:  Rheumatol Rehabil       Date:  1976-08

2.  Symposium on specific therapy for rheumatoid arthritis: specific therapy in new conventional animal models.

Authors:  P A Dieppe; D A Willoughby; C Stevens; J D Kirby; E C Huskisson
Journal:  Rheumatol Rehabil       Date:  1976-08

3.  Pertussis vaccine pleurisy: a model of delayed hypersensitivity.

Authors:  P A Dieppe; D A Willoughby; E C Huskisson; E Arrigoni-Martelli
Journal:  Agents Actions       Date:  1976-09

4.  Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.

Authors:  E C Huskisson; T J Gibson; H W Balme; H Berry; H C Burry; R Grahame; F D Hart; D R Henderson; J A Wojtulewski
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

5.  The mechanism of cutaneous hypersensitivity in the rat and its suppression by immunological methods.

Authors:  D A Willoughby
Journal:  J Pathol Bacteriol       Date:  1966-07

6.  Investigations on the influence of cyclophosphamide, gold sodium thiomalate and D-penicillamine on nystatin oedema and adjuvant arthritis.

Authors:  E Arrigoni-Martelld; E Bramm
Journal:  Agents Actions       Date:  1975-08

7.  Pertussis vaccine oedema: an experimental model for the action of penicillamine-like drugs.

Authors:  E Arrigoni-Martelli; E Bramm; E C Huskisson; D A Willoughby; P A Dieppe
Journal:  Agents Actions       Date:  1976-09

8.  Immunostimulant therapy with levamisole for rheumatoid arthritis.

Authors:  E C Huskisson; J Scott; H W Balme; P A Dieppe; J Trapnell; D A Willoughby
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321
  8 in total
  1 in total

1.  Assessment of drugs for activity in established type II collagen arthritis.

Authors:  S A Jones; A J Kennedy; N A Roberts
Journal:  Agents Actions       Date:  1982-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.